Executive Team
CEO
Christopher P. Karch, PhD
Area of Expertise/Focus: Vaccines, Adjuvants, Immunology, SAPN expert.
Chris is a UConn alumnus (2016) and a Fairfield University (2004) alumnus. He 2018 Maurice R. Hilleman Early-Stage Career Investigator Award winner.
CSO
Sharareh Emadi, PhD
Area of Expertise/Focus: Structural Biology, Nanotechnology, monoclonal antibody development.
COO
Peter Burkhard, PhD
Area of Expertise/Focus: Structural Biology, Nanotechnology, Biotechnology, Immunology. Peter is the inventor of the SAPN technology and has experience in all aspects developing SAPNs from basic science to GMP production, IND-application and phase I clinical trials.
Head Vaccine Development
Kamal ElBissati, PhD
Area of Expertise/Focus: Gene Knockout, Vaccines, Biotechnology, drug development. Kamal is a Fulbright US Scholar on medical sciences. He is a microbiologist, with a broad experience leading and managing projects, including preclinical and clinical studies to validate and advance potential new medicines/vaccines and novel diagnostic tools.